Low-Dose drug trial targets silent hormone problem
NCT ID NCT07104812
Summary
This study is testing whether a very low 1 mg dose of the drug osilodrostat is safe and can help control mild, ongoing overproduction of the stress hormone cortisol from the adrenal glands. It will involve 15 adults who have a benign adrenal tumor and related health issues like high blood pressure or bone thinning. Researchers will measure hormone levels in urine and blood to see if the drug reduces cortisol without causing side effects like adrenal insufficiency.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AUTONOMOUS CORTISOL SECRETION (ACS) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Mayo Clinic
RECRUITINGRochester, Minnesota, 55905, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.